Picture of Sapporo Clinical Laboratory logo

9776 — Sapporo Clinical Laboratory News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMicro CapSuper Stock

Table: Sapporo Clinical Lab -2015/16 parent results

May 13 (Reuters)-  
          Sapporo Clinical Laboratory Co Ltd  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to     NEXT      
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           16.27           15.74          16.28         8.12     
               (+3.4 pct)      (+3.5 pct)     (+0.0 pct)    (+1.2 pct)  
  Operating      933 mln         833 mln                                
               (+11.9 pct)     (-5.8 pct)                               
  Recurring      961 mln         865 mln        681 mln      363 mln    
               (+11.0 pct)     (-5.6 pct)     (-29.1 pct)  (-27.6 pct)  
  Net            569 mln         559 mln        448 mln      240 mln    
               (+1.9 pct)      (+13.7 pct)    (-21.3 pct)  (-24.6 pct)  
  EPS          163.80 yen      147.23 yen     128.97 yen    69.04 yen   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       11.00 yen       12.00 yen      11.00 yen                
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Sapporo Clinical Laboratory

See all news